Used in research as a potent and irreversible inhibitor of EGFR (epidermal growth factor receptor) and HER2, both of which are key targets in cancer therapy. Shows promising activity against tumor cells that overexpress these receptors, particularly in breast and non-small cell lung cancer models. Due to its irreversible binding mechanism, it provides prolonged suppression of receptor signaling, making it valuable in studying resistance mechanisms and pathway dynamics in oncology research. Also serves as a lead compound for developing targeted anticancer agents. Solubility and stability properties make it suitable for in vitro and in vivo experimental studies, especially in pharmacokinetics and efficacy evaluation.